AcouSort AB (publ) (STO:ACOU)
Sweden · Delayed Price · Currency is SEK 3.300
-0.080 (-2.37%)
Aug 13, 2026, 5:01 PM CET
AcouSort AB Market Cap
AcouSort AB has a market cap or net worth of 71.53 million as of August 13, 2026. Its market cap has decreased by -1.17% in one year.
Market Cap
71.53M
Enterprise Value
56.96M
Revenue
10.05M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.30
ChartMarket Cap Chart
Since January 9, 2017, AcouSort AB's market cap has increased from 65.36M to 71.53M, an increase of 9.45%. That is a compound annual growth rate of 0.95%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2026 | 71.53M | 19.43% |
| Dec 30, 2025 | 59.89M | -63.54% |
| Dec 30, 2024 | 164.28M | -29.12% |
| Dec 29, 2023 | 231.76M | 18.13% |
| Dec 30, 2022 | 196.19M | -41.95% |
| Dec 30, 2021 | 337.98M | 24.44% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jan 9, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Active Biotech AB | 139.18M |
| NextCell Pharma AB | 126.65M |
| Annexin Pharmaceuticals AB | 90.36M |
| OncoZenge AB | 84.57M |
| Ascelia Pharma AB | 77.98M |
| Spago Nanomedical AB | 76.08M |
| Pila Pharma AB | 61.44M |
| Disruptive Pharma AB | 59.21M |